By Bansari Mayur Kamdar and Johann M Cherian (Reuters) -The benchmark S&P 500 and the Dow climbed higher on Monday following a choppy week, with investors looking ahead to a...
Biogen (NASDAQ:BIIB) shares are trading higher premarket after topping second-quarter earnings and revenue expectations. The company also revealed it will cut jobs in order to save...
Investing.com - Biogen (NASDAQ: BIIB) reported second quarter EPS of $4.02, $0.24 better than the analyst estimate of $3.78. Revenue for the quarter came in at $2.46B versus the...
Investing.com -- U.S. stocks were rising ahead of fresh inflation data and the Federal Reserve’s latest decision on interest rates this week. At 9:39 ET (13:39 GMT), the Dow...
Investing.com -- Shares in Biogen Inc (NASDAQ:BIIB) surged in premarket trading on Monday after an advisory panel to U.S. regulators gave their support to the early-stage usage of...
Investing.com -- Biogen Inc. (NASDAQ:BIIB) announced that the Nasdaq (NASDAQ:NDAQ) exchange had halted trading of its stock on Friday. The move comes as advisors to the U.S. Food...
BofA Securities raised its price target on Biogen Inc (NASDAQ:BIIB) to $320.00 from $300.00 and maintained a Neutral rating following results from Eli Lilly and Company (NYSE:LLY)...
Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal...
Biogen Inc. (Nasdaq: BIIB) announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member of...